Literature DB >> 30864170

A case of woolly hair nevus, multiple linear pigmentation, and epidermal nevi with somatic HRAS p.G12S mutation.

Katsuhiko Nishihara1, Mikiko Tohyama1, Akiharu Kubo2.   

Abstract

Woolly hair nevus is a rare syndrome that presents as woolly hair in restricted areas of the scalp and may be associated with pigmented macules or epidermal nevus on the body. Here, we report a case of woolly hair nevus, linear pigmentation, and multiple epidermal nevi with a somatic HRAS c.34G>A(p.G12S) mutation.
© 2019 The Authors. Pediatric Dermatology Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30864170      PMCID: PMC6593414          DOI: 10.1111/pde.13783

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


CASE REPORT

A 5‐year‐old Japanese boy presented to the dermatology department with multiple linear pigmentations on the arms and trunk. Linear brown verrucous papules on the left forearm were noticed at about 9 months after birth (Figure 1A), and nuchal pigment macules were recognized at 1 year old. Linear and whorled hyperpigmentation then appeared gradually on the patient's back, axilla, and chest (Figure 1B). There was no hyperkeratosis of the palms or soles. Woolly hair was observed locally on the scalp (Figure 1C). Other than the skin manifestations, the patient did not exhibit any other symptoms. Neither the patient's parents nor his sister had woolly hair or linear pigmentation. Histopathologically, a skin biopsy specimen on the axilla with linear pigmentation showed hyperkeratosis, hypermelanosis, acanthosis, and papillomatosis of the epidermis that was consistent with an epidermal nevus (Figure 2). Genetic screening was conducted after obtaining written informed consent. Next‐generation sequencing of the genomic DNA purified from the epidermis of the epidermal nevus enzymatically separated from the dermis using custom‐targeted exome sequencing panels of the Haloplex target enrichment system.1 Sanger sequencing revealed an HRAS c.34G>A (p.G12S) mutation specifically in the epidermis but not in the dermis of the epidermal nevus and the blood (Figure 3). Analyses of the mRNA determined the identical HRAS mutation in the hair roots of the woolly hair but not of the straight hair (Figure 3). Echocardiography and abdominal ultrasound performed after genetic diagnosis showed no abnormal findings.
Figure 1

A, Clinical features. Note the linear brown verrucous papules on the left forearm. B, Linear and whorled hyperpigmentation on the back. C, Restricted woolly hair on the brown‐colored scalp

Figure 2

Skin biopsy histopathology. Hyperkeratosis, hypermelanosis, acanthosis, and papillomatosis of the epidermis were observed

Figure 3

Sanger sequencing chromatogram of the indicated samples showing a heterozygous. c.34G>A (p.G12S) mutation specifically in the woolly hair root and the epidermis from an epidermal nevus

A, Clinical features. Note the linear brown verrucous papules on the left forearm. B, Linear and whorled hyperpigmentation on the back. C, Restricted woolly hair on the brown‐colored scalp Skin biopsy histopathology. Hyperkeratosis, hypermelanosis, acanthosis, and papillomatosis of the epidermis were observed Sanger sequencing chromatogram of the indicated samples showing a heterozygous. c.34G>A (p.G12S) mutation specifically in the woolly hair root and the epidermis from an epidermal nevus

DISCUSSION

The occurrence of woolly hair nevus does not differ between sexes and usually appears within the first 2 years of life.2, 3 An association between pigmented macules, an epidermal nevus, or an ectopic mongolian spot with woolly hair nevus has been reported.2 In previous reports of woolly hair nevus, we found 10 cases associated with linear epidermal nevi. Genetic screening was performed in three patients, who all had HRAS p.G12S mosaic mutation, similar to our case.4, 5 HRAS encodes an oncogenic RAS protein, mutations of which cause various skin diseases. Hafner et al demonstrated that 26 of 72 cases of epidermal nevus had HRAS mutations, the major ones of which result in p.G13R, not p.G12S substitution.6 HRAS mutations were also observed in 62 of 65 and in 30 of 36 sebaceous nevus cases.7, 8 Almost all mutations result in p.G13R, not p.G12S substitutions.7 A heterozygous HRAS p.G12S mutation was demonstrated in the epidermal nevi of our case. The epidermal nevi were slightly elevated and located in areas of rubbing contact, such as the axilla and hands. Serial lesions on the arms and trunk looked like pigmented macules or linear pigmentations. Therefore, the HRAS p.G12S mutation may cause mild verrucous hyperplasia compared to the HRAS p.G13R mutation. Costello syndrome is a disease that produces various complications and is also caused by HRAS mutations.9, 10 Costello syndrome patients show growth and developmental delays, enlargement‐type cardiomyopathy, and frame abnormalities with dermatosis of woolly hair of the whole head, palmoplantar hyperkeratosis, papilloma, and acanthosis nigricans.11 Ninety percent of Costello syndrome patients showed HRAS p.G12S mutations.10 According to a report by Bertola et al.12 woolly hair was found in 88% of cases with HRAS p.G12S mutations and in 33% of cases with other mutation. Together, these results imply that the HRAS p.G12S mutation may play a significant role in the occurrence of woolly hair. Fifteen percent of Costello syndrome patients also develop malignant tumors.13 The most common tumor is rhabdomyosarcoma, mainly involving abdomen, pelvis, and urogenital area.13 In addition, neuroblastoma and bladder carcinoma have occurred in several patients.14 Rhabdomyosarcoma and neuroblastoma develop at a median age of 2.3 years and 1.4 years, respectively.14 These ages at the time of diagnosis are comparable with the ages expected for sporadic cancers. On the other hand, the median age at diagnosis of bladder carcinoma in 4 cases with Costello syndrome was 13.5 years, although bladder carcinoma most frequently occurs in the elderly.14 If epidermal nevus patients have the mosaic HRAS mutation not only in epidermal nevi but also in other tissues, they may be at risk of developing neoplasms similar to those found in Costello syndrome. One patient with epidermal nevi and HRAS p.G12S mosaic mutation was reported to develop urothelial cancer at 19 years old.15 Therefore, our patient began annual checks for malignancies at 7 years old by abdominal/pelvic ultrasonography and by urinalysis for hematuria, which is a proposed tumor screening protocol for Costello syndrome.13 In conclusion, woolly hair associated with epidermal nevi may be caused by a HRAS p.G12S mosaic mutation. If a HRAS p.G12S mutation is defined, periodical follow‐up is necessary to account for the risk of carcinogenesis from early childhood. Early genetic diagnosis may be important in these patients.
  15 in total

1.  HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.

Authors:  Christian Hafner; Agusti Toll; Francisco X Real
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

2.  Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.

Authors:  Leopold Groesser; Eva Herschberger; Arno Ruetten; Claudia Ruivenkamp; Enrico Lopriore; Markus Zutt; Thomas Langmann; Sebastian Singer; Laura Klingseisen; Wulf Schneider-Brachert; Agusti Toll; Francisco X Real; Michael Landthaler; Christian Hafner
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

Review 3.  The diagnosis of Costello syndrome: nomenclature in Ras/MAPK pathway disorders.

Authors:  Bronwyn Kerr; Judith Allanson; Marie Ange Delrue; Karen W Gripp; Didier Lacombe; Angela E Lin; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2008-05-01       Impact factor: 2.802

4.  Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.

Authors:  Christian P Kratz; Suthee Rapisuwon; Helen Reed; Henrik Hasle; Philip S Rosenberg
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-15       Impact factor: 3.908

5.  Woolly hair nevus associated with digital abnormalities and auditory disturbance.

Authors:  Kazutoshi Murao; Osamu Miyajima; Yoshiaki Kubo
Journal:  Int J Dermatol       Date:  2013-04-28       Impact factor: 2.736

6.  Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol.

Authors:  Karen W Gripp; Charles I Scott; Linda Nicholson; Donna M McDonald-McGinn; J Daniel Ozeran; Marilyn C Jones; Angela E Lin; Elaine H Zackai
Journal:  Am J Med Genet       Date:  2002-02-15

7.  Keratinocytic epidermal nevi are associated with mosaic RAS mutations.

Authors:  Christian Hafner; Agusti Toll; Susanne Gantner; Andreas Mauerer; Irene Lurkin; Francesco Acquadro; Alejandro Fernández-Casado; Ellen C Zwarthoff; Wolfgang Dietmaier; Eulalia Baselga; Elisabet Parera; Asunción Vicente; Ariel Casanova; Juan Cigudosa; Thomas Mentzel; Ramon M Pujol; Michael Landthaler; Francisco X Real
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

8.  Woolly hair nevus: a rare entity.

Authors:  V Venugopal; Subashini Karthikeyan; Pushpa Gnanaraj; Murali Narasimhan
Journal:  Int J Trichology       Date:  2012-01

9.  Germline mutations in HRAS proto-oncogene cause Costello syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Yukichi Tanaka; Mirella Filocamo; Kumi Kato; Yoichi Suzuki; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2005-09-18       Impact factor: 38.330

10.  Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome.

Authors:  Bryan K Sun; Andrea Saggini; Kavita Y Sarin; Jinah Kim; Latanya Benjamin; Philip E LeBoit; Paul A Khavari
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.